共 6 条
[3]
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)[J] . Ronald Emkey,William Koltun,Kathleen Beusterien,Larry Seidman,Alan Kivitz,Vipul Devas,Daiva Masanauskaite.Current Medical Research and Opinion? . 2005 (12)
[6]
Efficacy and tolerability of alendronateonce weekly in Asian postmenopausal osteoporotic women .2 Ho AY,Kung AW. Ann Pharmacother . 2005